NasdaqCM - Nasdaq Real Time Price USD

Brainstorm Cell Therapeutics Inc. (BCLI)

1.2400
+0.0200
+(1.64%)
At close: 4:00:01 PM EDT
1.2400
0.00
(0.00%)
After hours: 5:39:11 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
--
0
0
Operating Expense
12,308
11,693
--
24,822
24,539
Operating Income
-12,308
-11,693
--
-24,822
-24,539
Net Non Operating Interest Income Expense
-44
-77
--
545
82
Other Income Expense
1,266
147
--
--
--
Pretax Income
-11,086
-11,623
--
-24,277
-24,457
Net Income Common Stockholders
-11,086
-11,623
--
-24,277
-24,457
Diluted NI Available to Com Stockholders
-11,086
-11,623
--
-24,277
-24,457
Basic EPS
-2.01
-2.31
-6.00
-9.90
-10.20
Diluted EPS
-2.01
-2.31
-6.00
-9.90
-10.20
Basic Average Shares
5,528.3230
5,021.7980
2,871.7290
2,433.9370
2,412.1160
Diluted Average Shares
5,528.3230
5,021.7980
2,871.7290
2,433.9370
2,412.1160
Total Operating Income as Reported
-12,308
-11,693
--
-24,822
-24,539
Total Expenses
12,308
11,693
--
24,822
24,539
Net Income from Continuing & Discontinued Operation
-11,086
-11,623
--
-24,277
-24,457
Normalized Income
-12,352
-11,770
--
-24,277
-24,457
Interest Income
--
--
--
545
82
Net Interest Income
-44
-77
--
545
82
EBIT
-12,308
-11,693
-21,439
-24,822
-24,539
EBITDA
-12,080
-11,453
--
-24,537
-24,279
Reconciled Depreciation
228
240
265
285
260
Net Income from Continuing Operation Net Minority Interest
-11,086
-11,623
--
-24,277
-24,457
Total Unusual Items Excluding Goodwill
1,266
147
--
--
--
Total Unusual Items
1,266
147
--
--
--
Normalized EBITDA
-13,346
-11,600
--
-24,537
-24,279
Tax Rate for Calcs
0
0
--
0
0
Tax Effect of Unusual Items
0
0
--
0
0
12/31/2021 - 10/7/2003

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MTNB Matinas BioPharma Holdings, Inc.
0.8800
-5.37%
 
ZVSA ZyVersa Therapeutics, Inc.
0.6398
-2.31%
 
ENTO Entero Therapeutics, Inc.
0.5352
+2.92%
 
BDRX Biodexa Pharmaceuticals Plc
1.1500
0.00%
 
PCSA Processa Pharmaceuticals, Inc.
0.3247
+8.02%
 
ENVB Enveric Biosciences, Inc.
1.3000
-1.31%
 
KAPA Kairos Pharma, Ltd.
0.5666
+19.79%
 
REVB Revelation Biosciences, Inc.
0.8650
+0.58%
 
RENB Renovaro Inc.
0.3603
+16.64%
 
OSTX OS Therapies Incorporated
1.9800
+18.56%